semaglutide miami fl GLP-1 Weight Loss Clinic Serving Miami, Ozempic® & Wegovy® Weight-Loss Injections

The FDA Adverse Event Reporting System (FAERS) contains reports of musculoskeletal complaints associated with GLP-1 use, but such reports do not prove causation and may reflect coincidental associations or other contributing factors

Creatine and Caffeine: Considerations for Concurrent Supplementation

Sigalos JT, Pastuszak AW, Allison A, Ohlander SJ, Herati A, Lindgren MC, Lipshultz LI

National Health and Nutrition Examination Survey data found that the normal serum MMA range for the 2.5th to 97.5th percentile of people 70 years, who were considered to be vitamin B12-replete and with normal kidney function, was 84 to 317 nmol/l (Mineva, 2019)

Wegovy's FDA approval in 2021 combined with compelling clinical trial results (15%+ weight loss), celebrity adoption, and mainstream media coverage transformed GLP-1 from a specialty medication into a household name